Polymyositis-dermatomyositis and pregnancy
Keywords:
polymyositis and pregnancy, dermatomyositis and pregnancyAbstract
Polymyositis-dermatomyositis is a diffuse inflammatory disease of skeletal muscle of unknown etiology existing evidence of immunological factors in its pathogenesis .The incidence of the disease is low and involves mainly skin and muscles. It could be an acute ,sub acute and chronic illness which produces atrophy and degeneration of muscles .The idiopathic inflammatory myopathies are well defined considering etiopathogenic factors ,therapy and prognosis .However scientific reports do not make important differences between polymyositis and dermatomyositis .References of polymyositis-dermatomyositis and pregnancy are not common probably associated to the low incidence of the disease being the higher prevalence about the fifty years of age.
Downloads
References
Nava Arnulfo, Orozco-Barocio Gerardo. Abordaje en el diagnóstico diferencial de las miopatías inflamatorias. Miopatías inflamatorias. Reumatol Clin. 2009;5 Suppl 3:S32-4.
Hilton-Jones D. Observations on the classification of the inflammatory myopathies. Presse Med. 2011;40:199-208.
Amato AA, Barohn RJ. Evaluation and treatment of inflammatory myopathies. J Neurol Neurosurg Psychiatry. 2009;80:1060-8.
Berrocal Alfredo, Ramírez Erick, Calvo Armando. El embarazo no exacerba la dermatomiositis Rev Med Hered 1999;10 (3):125- 8.
Ricardo Y, Villa–Juárez M. Polimiositis/ dermatomiositis y embarazo. Rev. SaludmIL ITAR Mex. 2002;56(1):40 -5.
Mastaglia F.L., Phillips B.A. Idiopathic inflammatory myopathies: Epidemiology, classification, and diagnostic criteria. Rheum Dis Clin North Am.. 2002;28:723-41.
Vargas-Leguás H, Selva-O'Callaghan A, Campins-Martí M, Hermosilla Pérez E, Grau-Junyent JM, Martínez Gómez X, et al. [Polymyositis-dermatomyositis: incidence in Spain (1997-2004)]. Med Clin (Barc). 2007;129:721-4.
Hoogendijk J.E., Amato A.A., Lecky B.R., Choy E.H., Lundberg I.E., Rose M.R., et-al. 119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands. Neuromuscul Disord. 2004;14:337-45.
Selva O'Callaghan Albert, Trallero Araguás Ernesto. Miopatías inflamatorias. Dermatomiositis, polimiositis y miositis con cuerpos de inclusión. Reumatología Clínica. 2008;4(5):197-206.
Christopher-Stinea L, Plotz PH. Myositis: an update on pathogenesis. Curr Opin Rheumatol. 2004;16:700-6.
Okada S, Weatherhead E, Targoff IN, Wesley R, Miller FW, for the International Collaborative Study Group. Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune diseases. Arthritis Rheum. 2003;48:2285-93.
Selva-O'Callaghan A, Boeckh-Behrens TM, Balada-Prades E, Solans-Laque R, Vilardell-Tarrés M. Fetal microchimerism and inflammatory myopathies. Lancet. 2001;357:887-94.
Artlett CM, Ramos R, Jiminez SA, Patterson K, Miller FW, Rider LG. Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies. Childhood Myositis Heterogeneity Collaborative Group. Lancet. 2000;356:2155-6.
Selva-O'Callaghan A, Tura JM, Grau-Junyent JM, Labrador-Horrillo M, Solans-Laque R, Vilardell-Tarrés M. Silicone gel filled breast implants and dermatomyositis. Clin Exp Rheumatol. 2004;22:376-89.
Caramaschi P, Biasi D, Volpe A, Carletto A, Bambara LM. A new case of dermatomyositis following the rupture of a silicone gel breast implant. Clin Exp Rheumatol. 2005;23:430-1.
Selva-O'Callaghan A, Labrador-Horrillo M, Solans-Laque R, Simeon-Aznar CP, Martínez-Gómez X, Vilardell-Tarrés M. Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy. Arthritis Rheum. 2006;55:791-8.
Hengstman GJ, Ter Laak HJ, Vree Egberts WT, Lundberg IE, Moutsopoulos HM, Vencovsky J, et al. Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy. Ann Rheum Dis. 2006;65:1635-8.
Gunawardena H, Wedderburn LR, North J, Betteridge Z, Dunphy J, Chinoy H, et al. Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis. Rheumatology (Oxford). 2008;47:324-8.
FrederickW, MillerMD.Idiopathic inflammatory myopathies.Rheumatic Disease Clinics of North America. 2002; 4:833-52.
Spencer R. Inflammatory Muscle Disease. In West S (Ed): Rheumatology Secrets. Philadelphia, Hanley & Belfus. 1997:141-50.
Guzmán J, Petty RE, Malleson PN y cols. Monitoring disease activity in juvenile dermatomyositis: the role of Von Willebrand factor and muscle enzyme. J Rheumatol 1994;21(4):739-43.
Bohan A, Peter J, Browman R, et al. A computer analysis of 153 patients with PM/DM. Medicine. 1977;56:255-86.
Dalakas M.C., Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;362:971-82.
Briani C, Doria A, Sarzi-Puttini P, Dalakas M.C. Update on idiopathic inflammatory myopathies. Autoimmunity. 2006;39:161-70.
Mastaglia F.L. Inflammatory muscle diseases. Neurol India. 2008; 56:263-70.
Gerardo Gutiérrez-Gutiérreza; Carla Barbosa Lópeza; Francisco Navacerradab; Ambrosio Miralles Martíneza Utilidad del electromiograma en el diagnóstico de las miopatías inflamatorias. Revisiones. 2012;08(04).
Kyriakides T, Angelini C, Schaefer J, Sacconi S, Siciliano S, Vilchez JJ, et-al. EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia. Eur J Neurol. 2010;17:767-73.
Choy EH, Hoogendijk JE, Lecky B, Winer JB. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis. Cochrane Database Syst Rev. 2005;3(3).
Dalakas MC, Koffman B, Fujii M, Spector S, Sivakumar K, Cupler E, et al. A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM. Neurology. 2001;56:323-7.
Chung YL, Alexanderson H, Pipitone N, Morrison C, Dastmalchi M, Ståhl-Hallengren C, et al. Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: Six-month, double-blind, randomized, placebo-controlled trial. Arthritis Rheum. 2007;57:694-702.
Dastmalchi M, Grundtman C, Alexanderson H, Mavragani CP, Einarsdottir H, Barbasso Helmers S, et al. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies. Ann Rheum Dis. 2008;13.6(4):45-52.
Selva-O'Callaghan A, Labrador-Horrillo M, Vilardell-Tarres M. Specific biologic therapy with tumor necrosis factor inhibitors in patients with inflammatory myopathy. Curr Rheumatol Rev. 2005;1:157-65.
Guillermo Ruiz-Irastorzaa,b, María José Cuadradob,c y Munther A. Khamashtad Enfermedades autoinmunes sistémicas durante el embarazo: una aproximación práctica Med Clin (Barc) 1998;111:785-97.
Gutiérrez G, Dagnino R, Mintz G. Polymyositis/dermatomyositis andpregnancy. Arthritis Rheum. 1984;27:291-94.
Rosenzweig BA, Rotmensch S, Binette SP, Phillippe M. Primary idiopathic idiopathic polymyositis and dermatomyositis complicating pregnancy: diagnosisand management. Obstet Gynecol Surv 1989;44:162-70.
Pinheiro GRC, Goldenberg J, Atra E, Pereira RB, Camano I, Schmidt B. Juvenile dermatomyositis and pregnancy: report and literature review. JRheumatol. 1992;19(11):1798-801.
Oros J, Gil B, Risco Cortes R, et al. Miositis y gestación. Ginecol Obstet Mex 1994;62:103-06.
Arturo Juárez-Azpilcueta, Gonzalo Pol-Kipes, Gabriela Olivo-Arroyo, Arturo Ortiz-Pavón, Fausto Coronel-Cru Dermatomiositis y embarazo Gac Méd Méx. 2003;139(5):27-32.
Ishii N, Ono H, Kawaguchi T, Nakajima H. Dermatomyositis in pregnancy. Case report and review of the literature. Dermatologica 1991;183:146-49.
Friedman SA, Bernstein MS, Kitzmiller JL. Pregnancy complicated by collagen vascular disease. Obstet Gynecol Clin North Am. 1991;18:213-36.
England MJ, Perlmann T, Veriana Y. Dermatomyositis in pregnancy. Acase report. J Reprod Med 1986;31:633-36.
Williams L, Chang PY, Park E. Successful treatment of dermatomyositis during pregnancy with intravenous immunoglobulin monotherapy.Obstet Gynecol. 2007;109:561-63.
Harris A, Webley M, Usherwood M, Burge S. Dermatomyositis presenting in pregnancy. Br J Dermatol 1995;133:783-85.
Jeffrey P Callen, MD Dermatomyositis Article. Last Updated. 2008;8(2):21-45..
Vancsa A, Ponyi A, Constantin T. Pregnancy outcome in idiopathic inflammatory myopathy. Rheumatol Int. 2007;27:435-39.
Park IW, Suh YJ, Han JH, Choi JH. Suh CH.. Dermatomyositis developing in the first trimester of pregnancy. Korean J Intern Med. 2003;18(3):196-8.
Pasrija S, Rana R, Sardana K. A case of autoimmune myopathy in pregnancy. Indian J Med Sci. 2005;59:109-112.
Silva CA, Sultan SM, Isenberg DA. Pregnancy outcome in adult-onset idiopathic inflammatory myopathy. Rheumatology. 2003;42:1168-72.
WolfbergA J, Lee-Parritz A, Peller AJ, Lieberman ES. Association of rheumatologic disease with preeclampsia. Obstet Gynecol. 2004;103:1190-93.
Juanola Roura X, Ríos Rodríguez V, de la Fuente de Dios D. Fármacos durante el embarazo y métodos contraceptivos en enfermedades reumáticas. Nuevas aportaciones. Revisiones. 2010;06(01):28-37.
Ugarte A. Manejo del embarazo en pacientes con lupus eritematoso sistémico. Rev Clin.Esp. 2012;11.(03):65-72.
Ruiz-Irastorza G, Khamashta MA. Lupus and pregnancy: tenquestions and some answers. Lupus. 2008;17:416-20.
Seema Chopra, Vanita Suri, Rashmi B Agga, Autoimmune inflammatory Myopathy in Pregnancy Medscape. J Med. 2008;8(4):53-71.
Published
How to Cite
Issue
Section
License
Warning of rights of author
The authors that publish in this journal agree with the following terms:
The authors conserve the rights of author and concede to the journal the right of the first publication, fulfilling with the license Creative Commons Attribution License that allows to others share the work with recognition of the authorship of their articles, and the initial publication in this journal.
The authors can establish separately additional agreements for the no exclusive distribution of the version of the work published in the journal (for example, situate it in an institutional repository, in a personal blog or publish it partial or totally in a book), with a recognition of their initial publication in this journal.
To be able to send the manuscript or part of him passed three months of published, for his evaluation to other publishers, identifying it or not with the same title; whenever allusion is made to our journale and know it the new publisher.
The publishing committee of the Cuban Journal of Rheumatology authorizes to other publishers, to reproduce the articles published in our magazine, whenever it indicate the origin of the same.
The authors should send a document in Office Word application format through the electronic address of the magazine with a similar format to that we include next:
---------------------------------------------------------------------------------------------------------------------
Statement of authorship and cede of articles for the publication of the scientific work in the Cuban Journal of Rheumatology
Date:
Those who subscribe certify that are the authors of the work:
Of this form communicate the originality of our article clearing that the concepts and knowledges of other authors that have included in the text of the article, have been quoted properly in the bibliography.
We do proof besides that the article in question is original and has not been published, total neither partially, in another journal.
To be approved for his publication in the Cuban Journal of Rheumatology, do secession of the rights of publication to the same one through the method that realizes it usually.
In front of any catchword that exist by the article that send to evaluate, relieve of of the responsibility to the Cuban Journal of Rheumatology holding us responsible with all the difficulties that can berelated by any situation.
We include to continuation the name and the signature of all authors and collaborators of this article.
Name: Signature:
